REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 151 filers reported holding REVOLUTION MEDICINES INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,691,120 | +2.9% | 4,721,500 | -0.5% | 2.11% | +16.3% |
| Q2 2023 | $126,955,500 | +23.5% | 4,746,000 | -0.0% | 1.81% | +21.4% |
| Q1 2023 | $102,839,514 | -11.1% | 4,747,900 | -2.2% | 1.49% | -2.8% |
| Q4 2022 | $115,649,959 | +25.3% | 4,855,162 | +3.7% | 1.54% | +15.8% |
| Q3 2022 | $92,293,000 | +40.0% | 4,680,162 | +38.3% | 1.32% | +42.2% |
| Q2 2022 | $65,940,000 | -21.9% | 3,383,262 | +2.2% | 0.93% | -5.0% |
| Q1 2022 | $84,455,000 | -3.3% | 3,310,662 | -4.6% | 0.98% | +9.0% |
| Q4 2021 | $87,344,000 | -8.2% | 3,470,162 | +0.3% | 0.90% | -6.8% |
| Q3 2021 | $95,152,000 | +61.6% | 3,458,805 | +86.5% | 0.97% | +68.0% |
| Q2 2021 | $58,871,000 | +20.4% | 1,854,805 | +74.0% | 0.58% | +11.2% |
| Q1 2021 | $48,897,000 | +2986.9% | 1,065,770 | +2564.4% | 0.52% | +2772.2% |
| Q4 2020 | $1,584,000 | – | 40,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |